Page last updated: 2024-10-25

indibulin and Neuroblastoma

indibulin has been researched along with Neuroblastoma in 1 studies

indibulin: Tubulin Modulator/Antineoplastic Agent; structure in first source

Neuroblastoma: A common neoplasm of early childhood arising from neural crest cells in the sympathetic nervous system, and characterized by diverse clinical behavior, ranging from spontaneous remission to rapid metastatic progression and death. This tumor is the most common intraabdominal malignancy of childhood, but it may also arise from thorax, neck, or rarely occur in the central nervous system. Histologic features include uniform round cells with hyperchromatic nuclei arranged in nests and separated by fibrovascular septa. Neuroblastomas may be associated with the opsoclonus-myoclonus syndrome. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2099-2101; Curr Opin Oncol 1998 Jan;10(1):43-51)

Research Excerpts

ExcerptRelevanceReference
"Indibulin did not inhibit the binding of vinblastine or taxol to tubulin."1.91β-III Tubulin Levels Determine the Neurotoxicity Induced by Colchicine-Site Binding Agent Indibulin. ( Kumari, A; Panda, D; Prassanawar, SS, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Kumari, A1
Prassanawar, SS1
Panda, D1

Other Studies

1 other study available for indibulin and Neuroblastoma

ArticleYear
β-III Tubulin Levels Determine the Neurotoxicity Induced by Colchicine-Site Binding Agent Indibulin.
    ACS chemical neuroscience, 2023, 01-04, Volume: 14, Issue:1

    Topics: Animals; Antineoplastic Agents; Binding Sites; Colchicine; Humans; Molecular Docking Simulation; Neu

2023